AST2818

· Allist Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AST2818, covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations [NA]